Sanger sequencing…

The University of Virginia awarded a contract to Eurofins Genomics LLC on June 25, 2026, for the provision of Sanger sequencing services. The contract, identified as A207_PO-0452554, carries a cumulative value of twenty dollars and encompasses five units of Sanger sequencing, priced at four dollars per unit. Deliverables are to be directed to Gang Xiang. Sanger sequencing is a DNA sequencing methodology used for determining nucleotide sequences in biological samples, representing a fundamental molecular biology service offering.

This contract award represents a service procurement by a Virginia-based higher education institution. The modest contract value and limited quantity of sequencing reactions suggest this may constitute a small pilot engagement, a supplemental service order, or a discretionary procurement for specific research or administrative purposes within the University of Virginia's operations. No information regarding contract performance period, renewal options, or additional line items is available from the documentation provided.